Concepedia

Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma

Wen‐Lung Su, Shih‐Chang Chuang, Yu-Chu Wang, Lin-An Chen, Jian‐Wei Huang, Wen‐Tsan Chang, Shen‐Nien Wang, King‐Teh Lee, Chang‐Shen Lin, Kung‐Kai Kuo

Cancer Biomarkers · 2020 · 13 citations · 26 references

DOIFull text

Open access

Abstract

The co-expression of FOXM1 and Aurora-A could be a reliable biomarker to predict the sorafenib response and prognosis of HCC patients.

References

26

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 86.6K citations · Full text

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Aravind Subramanian, Pablo Tamayo, Vamsi K. Mootha et al. · Proceedings of the National Academy of Sciences · 2005 · 54.5K citations · Full text

, , +23

PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

Vamsi K. Mootha, Cecilia M. Lindgren, Karl‐Fredrik Eriksson et al. · Nature Genetics · 2003 · 10.4K citations

, , +10

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

Jan Budczies, Frederick Klauschen, Bruno V. Sinn et al. · PLoS ONE · 2012 · 1.3K citations · Full text

, , +20

Diagnosis of hepatocellular carcinoma

Eldad S. Bialecki, Adrian M. Di Bisceglie · HPB · 2005 · 330 citations · Full text